Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
66.56
+0.57 (0.86%)
At close: Dec 4, 2025, 4:00 PM EST
66.18
-0.05 (-0.08%)
Pre-market: Dec 5, 2025, 5:23 AM EST
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $4.79 billion as of December 5, 2025. Its market cap has increased by 74.35% in one year.
Market Cap
4.79B
Enterprise Value
3.87B
1-Year Change
74.35%
Ranking
Category
Stock Price
$66.56
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $4.79B, an increase of 473.88%. That is a compound annual growth rate of 39.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 4.77B | 82.89% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.13B |
| Johnson & Johnson | 493.66B |
| AbbVie | 396.78B |
| UnitedHealth Group | 294.05B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 251.38B |
| Abbott Laboratories | 219.01B |